Episode 214: hyperemesis treatment, Ca++ and Vit D, oral PCSK-9, and semaglutide for dementia (?)

<p>Primary care physicians Kate, Mark, Henry and Gary discuss 4 new studies that could change your practice: treatments for hyperemesis gravidarum, calcium and vitamin D to prevent falls and fractures in older adults, the first oral PCSK9 inhibitor, and oral semaglutide to treat dementia .</p><p>The John Hickner Memorial fund at MSU: <a href="https://give.msu.edu/?sid=17374"><u>https://give.msu.edu/?sid=17374</u></a> </p><p>Hyperemesis gravidarum treatments: <a href="https://pubmed.ncbi.nlm.nih.gov/41478546/"><u>https://pubmed.ncbi.nlm.nih.gov/41478546/</u></a> </p><p>Supplementing with calcium or vitamin D: <a href="https://pubmed.ncbi.nlm.nih.gov/42161415/"><u>https://pubmed.ncbi.nlm.nih.gov/42161415/</u></a> </p><p>Oral PCSK-9 enlicitide:  <a href="https://pubmed.ncbi.nlm.nih.gov/41879224/"><u>https://pubmed.ncbi.nlm.nih.gov/41879224/</u></a> </p><p>Cochrane review of PCSK-9s: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011748.pub3/full </p><p>Semaglutide for dementia: <a href="https://pubmed.ncbi.nlm.nih.gov/41865758/"><u>https://pubmed.ncbi.nlm.nih.gov/41865758/</u></a> </p><p><br></p>